Form D · Pharmaceuticals
Alterix Inc.
Beverly, MA · CIK 0001638851
Offering snapshot reported Sep 1, 2015 · SEC filing
- Reported sold
- $4.25M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 17, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 1, 2015 | Initial | $4,250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $600K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-246824
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Alexander Capital, LP | 40077 |
Source: Form D, filed Sep 1, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John J. Clark Jr. | Director |
| Frederic De Bure | Director |
| Janice D. Di Pietro, D.B.A. | Director |
| Galen Grayson, M.D. | Director |
| Frank A. Manguso | Director |
| Harry G. Mc Coy, Pharm.D. | Director |
| Patrick T. Mooney, M.D. | Director, Executive |
| David R. Staskin, M.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Cummings Center Suite 463 E
Beverly, MA, 01915
Beverly, MA, 01915